None listed
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. American Society of Anesthesiology Physical Classification (ASA PS) 2 to 3 patients 2. Patients who voluntarily gave written consent to participate in this clinical trial
Exclusion criteria
Exclusion criteria: 1. Patients diagnosed with arrhythmia 2. Patients with a pacemaker 3. Patients being treated for chronic pain 4. Patients diagnosed with autonomic nervous system diseases such as epilepsy 5. If anticholinergic drugs or vasoconstrictors were used before or during surgery 6. Patients judged unsuitable by other researchers
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Differences in ANI monitor measurements at the same 4-time points between the two groups | — |
Secondary
| Measure | Time frame |
|---|---|
| Blood pressure, pulse rate, effect site concentration of Remifentanil | — |
Countries
Korea, Republic of
Contacts
Chonnam National University Hospital